Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
98.5M
-
Number of holders
-
111
-
Total 13F shares, excl. options
-
67.6M
-
Shares change
-
+2.97M
-
Total reported value, excl. options
-
$478M
-
Value change
-
+$16.9M
-
Number of buys
-
64
-
Number of sells
-
-29
-
Price
-
$7.07
Significant Holders of Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) as of Q2 2024
130 filings reported holding ORIC - Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share as of Q2 2024.
Oric Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (ORIC) has 111 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.6M shares
of 98.5M outstanding shares and own 68.62% of the company stock.
Largest 10 shareholders include Nextech Invest Ltd. (5.29M shares), FMR LLC (4.92M shares), BlackRock Inc. (4.83M shares), VR Adviser, LLC (4.39M shares), Frazier Life Sciences Management, L.P. (4.14M shares), VIKING GLOBAL INVESTORS LP (4M shares), ALKEON CAPITAL MANAGEMENT LLC (3.8M shares), Column Group LLC (3.54M shares), EcoR1 Capital, LLC (3.42M shares), and VANGUARD GROUP INC (3.2M shares).
This table shows the top 111 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.